Tag Archive for PRO/AH/EDR> Chikungunya (04): Americas, Africa, Asia, Indian Ocean
PRO/AH/EDR> Chikungunya (04): Americas, Africa, Asia, Indian Ocean
Chikungunya -- HondurasEmergent BioSolutions has reported positive findings from the interim analysis of a phase II clinical trial being conducted to assess its chikungunya virus-like particle (CHIKV-VLP) vaccine candidate.According to the data, around 98% of the trial subjects who received a single dose of the vaccine generated a neutralising antibody response against the virus by day 7.The response was observed to be sustained through the 6-month visit."The phase II trial assessed the safety and Read more [...]
